Acute myeloid leukemia with multilineage dysplasia
MONDO:0019456An acute myeloid leukemia arising de novo and not as a result of treatment. It is characterized by the presence of myelodysplastic features in at least 50% of the cells of at least two hematopoietic cell lines. Patients often present with severe cytopenia.
Also known as: AML with multilineage dysplasia, AML with myelodysplasia-related features, De novo acute myeloid leukaemia with multilineage dysplasia, De novo acute myeloid leukemia with multilineage dysplasia, acute myeloid leukaemia with myelodysplasia-related features, acute myeloid leukemia with myelodysplasia-related features
3123 clinical trials for this condition and its sub-types, 34 tagged with Acute myeloid leukemia with multilineage dysplasia itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
-
New trial aims to wipe out hidden leukemia before transplant
Disease control Not yet recruitingThis Phase 2 trial tests whether adding other drugs to standard chemotherapy can eliminate leftover leukemia cells in adults aged 18-59 before a stem cell transplant. Participants who still have detectable disease after initial treatment will receive one of four drug combinations…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Can three routine blood ratios predict who survives AML?
Knowledge-focused Not yet recruitingResearchers at Assiut University Hospitals are studying whether three blood measures predict survival in adults newly diagnosed with non-M3 acute myeloid leukemia. The measures are the ratio of C-reactive protein to albumin, the ratio of albumin to fibrinogen, and the level of fe…
Sponsor: Assiut University • Aim: Knowledge-focused
Last updated Sep 11, 2026 00:00 UTC